Skip to content

Comparison of Two Urostomy Bags (2-piece).

A Comparative, Randomised, Crossover Study With SenSura Uro 2-piece Versus ConvaTec 2-piece Among 30 Urostomy-operated Persons in Germany

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00761748
Enrollment
30
Registered
2008-09-29
Start date
2008-09-30
Completion date
2009-02-28
Last updated
2013-01-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urostomy Patent

Keywords

Urostomy,, 2-piece,, preference,

Brief summary

Coloplast A/S has developed a new, improved 2-piece product for people with urostomies.

Detailed description

The 2-piece product is a part of a new product family, under the brand name SenSura. The aim of this investigation is to see how the urology product is perceived and how it performs against another 2-piece product from ConvaTec. The device 'ConvaTec 2-piece combihesive Natura' is selected as the comparative product because of its similarity to SenSura 2-piece product.

Interventions

DEVICEConvatec Uro 2-piece

Specific name of the device: 'Combihesive Natura® with a Durahesive Convex-It® base plate, 45 mm coupling, moldable (13-22 and 22-33 mm) hole size with boarder tape'. The subjects are asked to test each of the two products for 21 days plus/minus 3 days in a randomised order and in accordance with their normal frequency of change and normal use pattern. The duration of the clinical investigation should be enough time to identify any difference in user-preference. If the subject is in the middle of testing an urostomy base plate when the test period is turning into the next period, the urostomy base plate can be worn until it needs to be changed. It is not possible to blind the investigation as the appearance of the test- and refer-ence products are very different in the look.

DEVICESenSura Uro 2-piece

SenSura URO 2-piece Extended Wear, convex light, 50 mm coupling, cuttable (15-33 mm)

Sponsors

Coloplast A/S
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Be at least 18 years old, * Be able to complete a written consent form * Be able to fill in the Case Report Form * Have a urostomy with a diameter of 33 mm. or less. * Have had the urostomy for 3 months or more. * Use a 2-piece convex (or convex light) normally. * Be able to use SenSura URO 2-piece product * Be able to use ConvaTec, 2-piece product * Be able to handle the product themselves (application, removal and emptying),

Exclusion criteria

* In order to be enrolled in the clinical investigation, the subjects must not: * Need to use an ostomy belt * Be currently suffering from any dermatological problems, needing special treatment, on the peristomal skin * Being treated with chemo- or radiation therapy, * Be hospitalized during study enrollment, or have a hospitalization or significant surgery planned during the 4-week study period, or * Be pregnant or breast-feeding.

Design outcomes

Primary

MeasureTime frameDescription
Preference of the Two Urostomy Products6 weeksNumber of participants preferring the SenSura Uro 2 piece product or the reference Convatec 2 piece product. The subjects are asked via the case report form (questionnaire) at the end of the second cross over period, which of the two products they preferred.

Countries

Germany

Participant flow

Recruitment details

The subjects were recruited by the investigators at multiple sites in Germany.

Pre-assignment details

39 subjects were enrolled in the study, however 9 subjects were excluded from participating in the study.

Participants by arm

ArmCount
Overall Study Population
Urostomy operated subjects
30
Total30

Withdrawals & dropouts

PeriodReasonFG000FG001
First Intervention (21 +/- 3 Days)Adverse Event30
First Intervention (21 +/- 3 Days)Lost to Follow-up03

Baseline characteristics

CharacteristicOverall Study Population
Age Continuous68 years
Sex: Female, Male
Female
15 Participants
Sex: Female, Male
Male
15 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
5 / 300 / 30
serious
Total, serious adverse events
1 / 300 / 30

Outcome results

Primary

Preference of the Two Urostomy Products

Number of participants preferring the SenSura Uro 2 piece product or the reference Convatec 2 piece product. The subjects are asked via the case report form (questionnaire) at the end of the second cross over period, which of the two products they preferred.

Time frame: 6 weeks

Population: The Per protocol (PP) population is analysed. PP-criteria: Subjects fulfill the inclusion and exclusion criteria, do not seriously violate the protocol, are exposed to both products and are evaluable with respect to the primary endpoint (state preference). \*One drop out was evaluable, as the subject tried both products and stated a preference.

ArmMeasureValue (NUMBER)
Sensura Uro 2 PiecePreference of the Two Urostomy Products21 participants
Convatec 2 PiecePreference of the Two Urostomy Products4 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026